Premium
Further delineation of a rare recessive encephalomyopathy linked to mutations in GFER thanks to data sharing of whole exome sequencing data
Author(s) -
Nambot S.,
Gavrilov D.,
Theve J.,
Bruel A.L.,
Bainbridge M.,
Rio M.,
Goizet C.,
Rötig A.,
Jaeken J.,
Niu N.,
Xia F.,
Vital A.,
Houcinat N.,
Mochel F.,
Kuentz P.,
Lehalle D.,
Duffourd Y.,
Rivière J.B.,
ThauvinRobinet C.,
Beaudet A.L.,
Faivre L.
Publication year - 2017
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1111/cge.12985
Subject(s) - exome sequencing , compound heterozygosity , disease gene identification , mitochondrial disease , genetics , mitochondrial encephalomyopathy , biology , exome , phenotype , mitochondrial respiratory chain , genetic heterogeneity , mitochondrial myopathy , rare disease , mutation , mitochondrial dna , bioinformatics , medicine , disease , gene , pathology , mitochondrion
Background Alterations in GFER gene have been associated with progressive mitochondrial myopathy, congenital cataracts, hearing loss, developmental delay, lactic acidosis and respiratory chain deficiency in 3 siblings born to consanguineous Moroccan parents by homozygosity mapping and candidate gene approach (OMIM#613076). Next generation sequencing recently confirmed this association by the finding of compound heterozygous variants in 19‐year‐old girl with a strikingly similar phenotype, but this ultra‐rare entity remains however unknown from most of the scientific community. Materials and Methods Whole exome sequencing was performed as part of a “diagnostic odyssey” for suspected mitochondrial condition in 2 patients, presenting congenital cataracts, progressive encephalomyopathy and hypotrophy and detected unreported compound heterozygous variants in GFER . Results Thanks to an international data sharing, we found 2 additional patients carrying compound heterozygous variants in GFER. Reverse phenotyping confirmed the phenotypical similarities between the 4 patients. Together with the first literature reports, the review of these 8 cases from 4 unrelated families enables us to better describe this apparently homogeneous disorder, with the clinical and biological stigmata of mitochondrial disease. Conclusion This report highlights the clinical utility of whole exome sequencing and reverse phenotyping for the diagnosis of ultra‐rare diseases and underlines the importance of a broad data sharing for accurate clinical delineation of previously unrecognized entities.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom